Exceptional point (EP) is referred to degeneracies in a non-Hermitian system where two or more eigenvalues and their corresponding eigenvectors coalesce. Recently there have been significantly increased interests in harnessing EPs to enhance responsivities and achieve ultrasensitive detections in optics, electronics and acoustics, although there are few similar studies focused on using surface acoustic wave (SAW) sensing technologies, probably due to its great technical challenges. Herein, we proposed a scheme for accessing EPs in an on-chip architecture consisted of coupled-SAW-resonators system, forming a passive parity-time (PT) symmetric system. We demonstrated that by tuning additional losses in one of resonators and regulating the system in the proximity of the EP, the sensor exhibited significantly enhanced responses. As an example, we present an EP-based SAW gas sensor, which showed a much-improved sensitivity compared to that of a conventional delay-line SAW sensor. The fundamental mechanisms behind this excellent sensing performance have been elucidated.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41378-024-00864-5DOI Listing

Publication Analysis

Top Keywords

acoustic wave
8
wave sensing
8
harnessing exceptional
4
exceptional points
4
points ultrahigh
4
ultrahigh sensitive
4
sensitive acoustic
4
sensing exceptional
4
exceptional point
4
point referred
4

Similar Publications

Myringoplasty is most commonly used to treat tympanic membrane (TM) perforation. Clinical data have shown that unexplained high-frequency (above 3 kHz) hearing loss often occurs after myringoplasty. In this paper, a finite element (FE) model of the partial external and middle ear (ME) of the human ear, which considers the actual perforation and TM implants, is developed to reveal the mechanical mechanism of high-frequency hearing loss after implantation of temporalis fascia and cartilage commonly used in myringoplasty.

View Article and Find Full Text PDF

Objectives: A problem currently faced in the assessment of human exposure to the external environment concerns sources of noise with significant energy found in the range of infrasound and low sound frequencies. This paper presents an analysis of selected low-frequency noise (LFN) sources in order to demonstrate the problem of the potential exposure of humans residing in their vicinity. There are numerous machines in industry that emit LFN, including infrasound, such as ventilation systems, industrial fans, air and exhaust transfer systems, means of transport and other objects that generate secondary noise, such as acoustic screens.

View Article and Find Full Text PDF

Rhinoplasty is the most common cosmetic surgery procedure in Iran. One of the complications of this procedure that has been less considered is the probable effect of rhinoplasty on voice. This study aimed to assess the influence of rhinoplasty on acoustic characteristics of resonance and sound production.

View Article and Find Full Text PDF

Impact of Otoplasty on Speech Intelligibility and Auditory Function in Noise.

Indian J Otolaryngol Head Neck Surg

January 2025

The Division of Otolaryngology, Melhem International Hospital, Baku, Azerbaijan.

Prominent ear deformity, affecting up to 5% of the white population, is characterized by an absent antihelical fold and conchal cartilage hypertrophy. These anatomical changes can potentially alter auditory function, including speech intelligibility in noise. To evaluate changes in auditory function, particularly speech intelligibility in noise, following otoplasty for prominent ear deformities.

View Article and Find Full Text PDF

Introduction: Triple-negative breast cancer (TNBC) is known for its high malignancy, limited clinical treatment options, and poor chemotherapy outcomes. Although some advancements have been made using nanotechnology-based chemotherapy for TNBC treatment, the controlled and on-demand release of chemotherapeutic drugs at the tumor site remains a challenge.

Methods: We manufactured DOX/BaTiO@cRGD-Lip (DBRL) nanoparticles as an ultrasound (US)-controlled release platform targeting the delivery of Doxorubicin (DOX) for TNBC treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!